Isoflurane protects renal function against ischemia and reperfusion through inhibition of protein kinases, JNK and ERK.
Isoflurane protects renal function against ischemia and reperfusion through inhibition of protein kinases, JNK and ERK.
批准号:
15591639
负责人:
MOROOKA Hiroaki
金额:
$1.79万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005
中文摘要
缺血/再灌注损伤(IRI)是外科手术中的主要问题。异氟烷对心脏和大脑中的IR具有药理学预处理作用,但这是否也发生在肾脏中尚不清楚。在这项研究中,我们测试的假设,异氟醚对IRI在大鼠肾脏的保护作用,并进一步JNK抑制有助于这种保护作用。F组仅行假手术。G组在假手术前吸入1.5%异氟醚。H组和I组通过夹闭肾蒂使左肾缺血40分钟。I组在肾缺血前吸入1.5%异氟醚20 min。分别于缺血再灌注0、5、40、90 min和假手术后40 min取肾,检测JNK活性,H组(缺血组)JNK活性在再灌注后5 min即明显激活,40 min达高峰,并维持较高水平至再灌注后90 min。I组(异氟醚)再灌注后40 ~ 90 min JNK活性显著低于H组。我们的结论是,异氟醚有保护作用,对肾IRI时,缺血前给药,该效果将涉及抑制JNK。
英文摘要
Ischemia/reperfusion injury (IRI) is a major problem in the surgery. Isoflurane has a pharmacological preconditioning effect against IR in the heart and brain, but whether this also occurs in the kidney is still unclear. In this study, we tested the hypothesis that isoflurane had a protective effect against IRI in the rat kidney, and further that JNK inhibition contributed this protective effect.Animals were randomly divided into four groups. Group F underwent sham surgery only. Group G received 1.5% isoflurane before sham surgery. Groups H and I were subjected to 40-min left renal ischemia by clamping the renal pedicles. Group I received 1.5% isoflurane for 20 min before renal ischemia. Ischemic kidneys were harvested at 0, 5, 40 and 90 min after starting reperfusion, and sham kidneys were harvested at 40 min after sham surgery, for measurement of JNK activities.JNK was markedly activated as early as 5 min after starting reperfusion, with a peak at 40 min, and remained at a relatively high level until 90 min after starting reperfusion in group H (ischemia only). The activity of JNK in group I (with isoflurane) was significantly lower than in group H from 40 to 90 min after starting reperfusion. We conclude that isoflurane has a protective effect against renal IRI when administered before ischemia and that the effect would involve the inhibition of JNK.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1213/01.ane.0000184044.51749.b8
发表时间:
2005-12-01
期刊:
ANESTHESIA AND ANALGESIA
影响因子:
5.7
作者:
[Hashiguchi, H, Morooka, H, Sumikawa, K]
通讯作者:
Sumikawa, K
DOI:
10.1007/s00540-005-0322-4
发表时间:
2005-08
期刊:
Journal of Anesthesia
影响因子:
2.8
作者:
[Y. Terao;Toshiaki Nakamura;H. Morooka;K. Sumikawa]
通讯作者:
Y. Terao;Toshiaki Nakamura;H. Morooka;K. Sumikawa
Masanori Matsumoto, et al.: "Isoflurane inhibits NFkB activation in response to simulated ischemia in renal tubular cell line"Anesthesiology. 99. A1545 (2003)
Masanori Matsumoto 等人:“异氟醚抑制肾小管细胞系中模拟缺血反应中的 NFkB 激活”麻醉学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Effect of Cyclooxygenase-2 inhibitor pretreatment on gas exchange after hydrochloric acid asniration in rats.
环氧合酶 2 抑制剂预处理对大鼠盐酸吸入后气体交换的影响。
DOI:
--
发表时间:
2005
期刊:
Journal of Anesthesia 19
影响因子:
--
作者:
[Yoshiaki Terao, Hiroaki Morooka, et al.]
通讯作者:
et al.
Hideo Hashiguchi, et al.: "Pharmacological preconditioning effect of isoflurane against renal ischemia/reperfusion injure in rats"Anesthesiology. 99. A83 (2003)
Hideo Hashiguchi 等人:“异氟烷对大鼠肾缺血/再灌注损伤的药理预处理作用”麻醉学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 7 条
Pharmacological preconditioning effect of isoflurane against renal ischemia/reperfusion injury in rats.
-
批准号:14571448
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2002
-
负责人:MOROOKA Hiroaki
-
依托单位:
N-acetyl-L-cysteine inhibits activitation of p38 MAP kinase in heat stressed heart
-
批准号:11671507
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:1999
-
负责人:MOROOKA Hiroaki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
丁酸通过抑制p38/ERK/JNK信号通路重建Treg/Th17平衡缓解艰难梭菌结肠炎的机制研究
-
批准号:2026JJ82452
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:段菊屏
-
依托单位:
circFOXM1通过CTCF/TP53轴调控糖酵解与JNK通路诱导胶质瘤替莫唑胺耐药的机制与转化研究
-
批准号:2026JJ82323
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚勇
-
依托单位:
DUSP10通过抑制JNK/P38延缓肾脏缺血再灌注纤维化的关键机制研究
-
批准号:2026JJ50647
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:郭勇
-
依托单位:
CDH5介导p38/JNK通路调控糖尿病视网膜病变的分子机制及干预探索
-
批准号:2026JJ80392
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王桂芳
-
依托单位:
血清外泌体miR-502-5p下调TRAF2/ASK1/JNK通路介导的内质网应激改善脓毒症相关急性肾损伤作用机制的研究
-
批准号:2026JJ82612
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张鹰
-
依托单位:
呼吸道合胞病毒通过CXCL10-CXCR3/JNK/JUN/SPI1轴调控巨噬细胞OLAH介导的油酸代谢在急性呼吸窘迫综合征中的机制研究
-
批准号:2026JJ60058
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:唐中湘
-
依托单位:
NSAIDs与硫化氢联合通过激活JNK通路及调控ROS水平诱导胃癌细胞凋亡的机制研究
-
批准号:2026JJ81993
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:肖政
-
依托单位:
基于JNK/FoxO1通路探讨黄连解毒汤抑制血管性痴呆大鼠铁死亡的作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:杨梦琳
-
依托单位:
METTL3介导m6A修饰的TAB2/TAK1/JNK信号轴在阻碍细胞迁移导致尿道下裂发生中的机制
-
批准号:2025JJ70119
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李明勇
-
依托单位:
USP11介导的CDK10去泛素化调控JNK/c-JUN信号通路抑制肺癌肿瘤形成与放疗抵抗的作用与机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:黄玉美
-
依托单位: